COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 315 | 6 | 313 | 39 | 475 | 96 | 584 |
ERLYTX | 40 | 1 | 52 | 3 | 37 | 7 | 43 |
GI | 211 | 5 | 261 | 16 | 195 | 38 | 231 |
GU | 522 | 8 | 417 | 38 | 463 | 85 | 517 |
LEUK | 50 | 0 | 0 | 5 | 61 | 8 | 49 |
LUNG | 814 | 10 | 522 | 57 | 694 | 121 | 737 |
LYMPH | 190 | 9 | 470 | 18 | 219 | 38 | 231 |
MELAN | 457 | 3 | 157 | 40 | 487 | 94 | 572 |
MMYEL | 194 | 7 | 365 | 22 | 268 | 58 | 353 |
MULT | 18 | 0 | 0 | 3 | 37 | 7 | 43 |
OTHER | 61 | 1 | 52 | 7 | 85 | 17 | 103 |
PREV | 4 | 0 | 0 | 0 | 0 | 1 | 6 |
SXQOL | 6 | 0 | 0 | 1 | 12 | 2 | 12 |
Total | 2882 | 50 | 2609 | 249 | 3033 | 572 | 3481 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 2 | 0 | 0 | 1 | 12 | 1 | 6 |
CCD | 904 | 18 | 939 | 73 | 889 | 133 | 810 |
ERLYTX | 10 | 0 | 0 | 1 | 12 | 2 | 12 |
GI | 4 | 0 | 0 | 2 | 24 | 4 | 24 |
GU | 8 | 0 | 0 | 1 | 12 | 5 | 30 |
LEUK | 5 | 0 | 0 | 5 | 61 | 5 | 30 |
LUNG | 339 | 9 | 470 | 29 | 353 | 54 | 329 |
OTHER | 9 | 0 | 0 | 2 | 24 | 3 | 18 |
PEOLC | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 541 | 1 | 52 | 19 | 231 | 56 | 341 |
SURV | 10 | 0 | 0 | 1 | 12 | 4 | 24 |
SXQOL | 1362 | 12 | 626 | 37 | 450 | 94 | 572 |
Total | 3206 | 40 | 2087 | 171 | 2080 | 361 | 2196 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 317 | 6 | 313 | 40 | 487 | 97 | 590 |
CCD | 904 | 18 | 939 | 73 | 889 | 133 | 810 |
ERLYTX | 50 | 1 | 52 | 4 | 49 | 9 | 55 |
GI | 215 | 5 | 261 | 18 | 219 | 42 | 256 |
GU | 530 | 8 | 417 | 39 | 475 | 90 | 548 |
LEUK | 55 | 0 | 0 | 10 | 122 | 13 | 79 |
LUNG | 1153 | 19 | 991 | 86 | 1047 | 175 | 1065 |
LYMPH | 190 | 9 | 470 | 18 | 219 | 38 | 231 |
MELAN | 457 | 3 | 157 | 40 | 487 | 94 | 572 |
MMYEL | 194 | 7 | 365 | 22 | 268 | 58 | 353 |
MULT | 18 | 0 | 0 | 3 | 37 | 7 | 43 |
OTHER | 70 | 1 | 52 | 9 | 110 | 20 | 122 |
PEOLC | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 545 | 1 | 52 | 19 | 231 | 57 | 347 |
SURV | 10 | 0 | 0 | 1 | 12 | 4 | 24 |
SXQOL | 1368 | 12 | 626 | 38 | 463 | 96 | 584 |
Total | 6088 | 90 | 4695 | 420 | 5115 | 933 | 5679 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 191 | 5 | 261 | 26 | 317 | 58 | 353 |
ERLYTX | 31 | 0 | 0 | 0 | 0 | 3 | 18 |
GI | 177 | 5 | 261 | 12 | 146 | 32 | 195 |
GU | 423 | 3 | 157 | 29 | 353 | 70 | 426 |
LEUK | 30 | 0 | 0 | 2 | 24 | 4 | 24 |
LUNG | 545 | 7 | 365 | 40 | 487 | 77 | 469 |
LYMPH | 156 | 6 | 313 | 12 | 146 | 27 | 164 |
MELAN | 271 | 0 | 0 | 21 | 256 | 52 | 317 |
MMYEL | 128 | 4 | 209 | 12 | 146 | 34 | 207 |
MULT | 8 | 0 | 0 | 2 | 24 | 4 | 24 |
OTHER | 61 | 1 | 52 | 7 | 85 | 17 | 103 |
PREV | 4 | 0 | 0 | 0 | 0 | 1 | 6 |
SXQOL | 6 | 0 | 0 | 1 | 12 | 2 | 12 |
Total | 2031 | 31 | 1618 | 164 | 1996 | 381 | 2318 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 2 | 0 | 0 | 1 | 12 | 1 | 6 |
CCD | 796 | 15 | 783 | 62 | 755 | 118 | 718 |
ERLYTX | 10 | 0 | 0 | 1 | 12 | 2 | 12 |
GI | 4 | 0 | 0 | 2 | 24 | 4 | 24 |
GU | 8 | 0 | 0 | 1 | 12 | 5 | 30 |
LUNG | 195 | 4 | 209 | 12 | 146 | 30 | 183 |
OTHER | 9 | 0 | 0 | 2 | 24 | 3 | 18 |
PEOLC | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 372 | 1 | 52 | 19 | 231 | 51 | 310 |
SURV | 10 | 0 | 0 | 1 | 12 | 4 | 24 |
SXQOL | 879 | 8 | 417 | 25 | 304 | 59 | 359 |
Total | 2291 | 28 | 1461 | 126 | 1532 | 277 | 1684 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 247 | 8 | 417 | 36 | 438 | 77 | 469 |
CCD | 812 | 14 | 730 | 63 | 767 | 119 | 724 |
ERLYTX | 41 | 0 | 0 | 1 | 12 | 5 | 30 |
GI | 185 | 5 | 261 | 15 | 183 | 35 | 213 |
GU | 444 | 6 | 313 | 34 | 414 | 80 | 487 |
LEUK | 30 | 0 | 0 | 2 | 24 | 4 | 24 |
LUNG | 740 | 11 | 574 | 52 | 633 | 107 | 651 |
LYMPH | 156 | 6 | 313 | 12 | 146 | 27 | 164 |
MELAN | 271 | 0 | 0 | 21 | 256 | 52 | 317 |
MMYEL | 129 | 5 | 261 | 13 | 158 | 35 | 213 |
MULT | 14 | 1 | 52 | 3 | 37 | 7 | 43 |
OTHER | 87 | 2 | 104 | 12 | 146 | 25 | 152 |
PEOLC | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 376 | 1 | 52 | 19 | 231 | 52 | 317 |
SURV | 10 | 0 | 0 | 1 | 12 | 4 | 24 |
SXQOL | 885 | 8 | 417 | 26 | 317 | 61 | 371 |
Total | 4433 | 67 | 3494 | 310 | 3774 | 690 | 4199 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 267 | 6 | 313 | 38 | 463 | 91 | 554 |
ERLYTX | 34 | 1 | 52 | 3 | 37 | 7 | 43 |
GI | 91 | 2 | 104 | 9 | 110 | 16 | 97 |
GU | 261 | 6 | 313 | 17 | 207 | 35 | 213 |
LEUK | 37 | 0 | 0 | 5 | 61 | 7 | 43 |
LUNG | 755 | 8 | 417 | 54 | 657 | 116 | 706 |
LYMPH | 128 | 6 | 313 | 14 | 170 | 29 | 177 |
MELAN | 9 | 0 | 0 | 0 | 0 | 4 | 24 |
MMYEL | 172 | 7 | 365 | 22 | 268 | 55 | 335 |
MULT | 18 | 0 | 0 | 3 | 37 | 7 | 43 |
Total | 1772 | 36 | 1877 | 165 | 2010 | 367 | 2235 |
Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
Member | 1888 | 22 | 1148 | 126 | 1534 | 314 | 1911 |
AFFIL | 241 | 4 | 209 | 24 | 292 | 50 | 304 |
CCOP/NCORP | 2193 | 33 | 1722 | 140 | 1705 | 294 | 1790 |
Non-SWOG | 1763 | 28 | 1461 | 127 | 1546 | 272 | 1656 |
Total | 6085 | 87 | 4540 | 417 | 5077 | 930 | 5661 |
ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
---|---|---|---|---|---|
CCD | NHLBIMDS | LEUK, National MDS Study | 1 | E | 24-JUN-24 |
MELAN | S2000 | MELAN, M1d/ BRAF, Enco+Bini+Nivo vs Ipil+Nivo | 1 | N | 18-JUN-24 |
BREAST | S1706 | Breast, Inflammatory, RT +/- Olaparib | 1 | N | 01-JUL-24 |
MELAN | EA6174 | Merkel, Adjuvant Pembrolizumab vs Observation | 1 | E | 01-JUL-24 |
ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
---|---|---|---|---|
CCD | S2108CD | Genomic Tumor Board vs Usual Practice | 1 | 14 |
LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 9 |
MMYEL | S1803 | MM, Maintenance, Len vs Len/Dara | 1 | 6 |
MMYEL | S1803 | MM, Maintenance, Len vs Len/Dara | 2 | 6 |
SXQOL | S2010 | ASPEN: Brst, Stg I-III, ASM vs Pt Ed | 1 | 6 |
BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 6 |
BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 6 |
LUNG | S2302 | NSCLC, Stg IV or Recur, Ramu + Pembro vs SoC | 1 | 6 |
SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
GU | A031704 | RCC, Met, Ipi+Nivo followed by Nivo+/-Cabo | 2 | 3 |
CCD | S1912CD | CREDIT, Fin Counseling to reduce Fin Hardship | 1 | 3 |
GU | S1931 | RENAL, Stg IV, IO + Nephrectomy. vs IO Only | 1 | 3 |
MELAN | S2015 | MELAN, Stg I-II, 1cm v 2cm excision margins | 1 | 3 |
LYMPH | S2114 | NHL, Rel/Ref, CD19 CAR-T +/- Consolidation | 1 | 3 |